Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Abstract
Article Tools ASCO SPECIAL ARTICLE Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.1999.17.9.2971 Journal of Clinical Oncology - published online before print September 21, 2016 PMID: 10561376 Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines Richard J. GrallaxRichard J. GrallaSearch for articles by this author , David OsobaxDavid OsobaSearch for articles by this author , Mark G. KrisxMark G. KrisSearch for articles by this author , Peter KirkbridexPeter KirkbrideSearch for articles by this author , Paul J. HeskethxPaul J. HeskethSearch for articles by this author , Lawrence W. ChinneryxLawrence W. ChinnerySearch for articles by this author , Rebecca Clark-SnowxRebecca Clark-SnowSearch for articles by this author , David P. GillxDavid P. GillSearch for articles by this author , Susan GroshenxSusan GroshenSearch for articles by this author , Steven GrunbergxSteven GrunbergSearch for articles by this author , James M. KoellerxJames M. KoellerSearch for articles by this author , Gary R. MorrowxGary R. MorrowSearch for articles by this author , Edith A. PerezxEdith A. PerezSearch for articles by this author , Jeffrey H. SilberxJeffrey H. SilberSearch for articles by this author , David G. PfisterxDavid G. PfisterSearch for articles by this author , Show More From the American Society of Clinical Oncology, Alexandria, VA. https://doi.org/10.1200/JCO.1999.17.9.2971 First Page Full Text PDF Figures and Tables © 1999 by American Society of Clinical Oncology
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ozer, H., Armitage, J. O., Bennett, C. L., Crawford, J., Demetri, G. D., Pizzo, P. A., Schiffer, C. A., Smith, T. J., Somlo, G., Wade, J. C., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.20.3558 · Cited by 1,044
Gralla, R. J., Itri, L. M., Pisko, S. E., Squillante, A. E., Kelsen, D. P., Braun, D. W., Bordin, L. A., Braun, T. J., & Young, C. W. (1981) · New England Journal of Medicine · doi:10.1056/nejm198110153051601 · Cited by 705
Self-citationDombernowsky, P., Smith, I., Falkson, G., Leonard, R., Panasci, L., Bellmunt, J., Bezwoda, W., Gardin, G., Gudgeon, A., Morgan, M., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.453 · Cited by 638
Proposal for classifying the acute emetogenicity of cancer chemotherapy.
Hesketh, P. J., Kris, M. G., Grunberg, S. M., Beck, T., Hainsworth, J. D., Harker, G., Aapro, M. S., Gandara, D., & Lindley, C. M. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.103 · Cited by 605
Self-citationCurrent Status of Benzodiazepines
Koch-Weser, J., Greenblatt, D. J., Shader, R. I., & Abernethy, D. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090705 · Cited by 451
(1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.11.2471 · Cited by 436
Cubeddu, L. X., Hoffmann, I. S., Fuenmayor, N. T., & Finn, A. L. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003223221204 · Cited by 407
Marty, M., Pouillart, P., Scholl, S., Droz, J. P., Azab, M., Brion, N., Pujade-Lauraine, E., Paule, B., Paes, D., & Bons, J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003223221205 · Cited by 406
Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptors
Butler, A., Hill, J. M., Ireland, S. J., Jordan, C. C., & Tyers, M. B. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11542.x · Cited by 374
Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy
Sallan, S. E., Zinberg, N. E., & Frei, E. (1975) · New England Journal of Medicine · doi:10.1056/nejm197510162931603 · Cited by 364
Kris, M. G., Gralla, R. J., Clark, R. A., Tyson, L. B., O'Connell, J. P., Wertheim, M. S., & Kelsen, D. P. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.10.1379 · Cited by 336
Self-citationBehavioral Treatment for the Anticipatory Nausea and Vomiting Induced by Cancer Chemotherapy
Morrow, G. R., & Morrell, C. (1982) · New England Journal of Medicine · doi:10.1056/nejm198212093072402 · Cited by 307
Self-citation(1995) · New England Journal of Medicine · doi:10.1056/nejm199501053320101 · Cited by 263
Sallan, S. E., Cronin, C., Zelen, M., & Zinberg, N. E. (1980) · New England Journal of Medicine · doi:10.1056/nejm198001173020302 · Cited by 261
CHANG, A. E., SHILING, D. J., STILLMAN, R. C., GOLDBERG, N. H., SEIPP, C. A., BAROFSKY, I., SIMON, R. M., & ROSENBERG, S. A. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-6-819 · Cited by 259
Current Status of Benzodiazepines
Koch-Weser, J., Greenblatt, D. J., Shader, R. I., & Abernethy, D. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308113090607 · Cited by 249
Kris, M. G., Gralla, R. J., Tyson, L. B., Clark, R. A., Cirrincione, C., & Groshen, S. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.1.108 · Cited by 236
Self-citationRecent clinical experience with dronabinol
Plasse, T. F., Gorter, R. W., Krasnow, S. H., Lane, M., Shepard, K. V., & Wadleigh, R. G. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90385-f · Cited by 224
Redd, W. H., Jacobsen, P. B., Die-Trill, M., & Dermatis, H. (1987) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.55.3.391 · Cited by 224
Osoba, D., Zee, B., Pater, J., Warr, D., Latreille, J., & Kaizer, L. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.116 · Cited by 218
Self-citationHerman, T. S., Einhorn, L. H., Jones, S. E., Nagy, C., Chester, A. B., Dean, J. C., Furnas, B., Williams, S. D., Leigh, S. A., Dorr, R. T., et al. (1979) · New England Journal of Medicine · doi:10.1056/nejm197906073002302 · Cited by 216
FRYTAK, S., MOERTEL, C. G., O'FALLON, J. R., RUBIN, J., CREAGAN, E. T., O'CONNELL, M. J., SCHUTT, A. J., & SCHWARTAU, N. W. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-6-825 · Cited by 201
Nonsteroidal antiinflammatory drugs and colorectal cancer
Muscat, J. E., Stellman, S. D., & Wynder, E. L. (1994) · Cancer · doi:10.1002/1097-0142(19941001)74:7<1945::aid-cncr2820740720>3.0.co;2-c · Cited by 198
(1998) · Annals of Oncology · doi:10.1023/a:1008471812316 · Cited by 185
Antiemetic Efficacy of Dexamethasone
Markman, M. M., Sheidler, V. R., Ettinger, D. S., Quaskey, S. A., & Mellits, E. D. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408303110901 · Cited by 175
Serotonin Antagonists: A New Class of Antiemetic Agents
Hesketh, P. J., & Gandara, D. R. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.9.613 · Cited by 161
Self-citationConditioned side effects induced by cancer chemotherapy: Prevention through behavioral treatment.
Burish, T. G., Carey, M. P., Krozely, M. G., & Greco, F. A. (1987) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.55.1.42 · Cited by 158
Zeltzer, L. K., Dolgin, M. J., LeBaron, S., & Lebaron, C. (1991) · PEDIATRICS · doi:10.1542/peds.88.1.34 · Cited by 157
Hainsworth, J. D., Harvey, W. H., Pendergrass, K. B., et al. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.5.721 · Cited by 154
Antiemetic Efficacy of Dexamethasone Therapy in Patients Receiving Cancer Chemotherapy
Cassileth, P. A., Lusk, E. J., Torri, S., DiNubile, N., & Gerson, S. L. (1983) · Archives of Internal Medicine · doi:10.1001/archinte.1983.00350070063012 · Cited by 146
Aapro, M., Plezia, P. M., Alberts, D. S., Graham, V. M., Jones, S., Surwit, E. A., & Moon, T. E. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.5.466 · Cited by 145
Hesketh, P. J., Navari, R. M., Grote, T., Gralla, R. J., Hainsworth, J. D., Kris, M. G., Anthony, L. B., Khojasteh, A., Tapazoglou, E., Benedict, C. R., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.8.2242 · Cited by 145
Self-citationBehavioral intervention in cancer treatment: Controlling aversion reactions to chemotherapy.
Redd, W. H., & Andrykowski, M. A. (1982) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.50.6.1018 · Cited by 144
Perez, E. A., Hesketh, P. J., Sandbach, J. F., Reeves, J., Chawla, S., Markman, M. M., Hainsworth, J. D., Bushnell, W., & Friedman, C. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.754 · Cited by 136
Self-citationHesketh, P. J., Harvey, W. H., Harker, W. G., et al. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.596 · Cited by 132
Self-citationNavari, R. M., Gandara, D. R., Hesketh, P. J., Hall, S., Mailliard, J. A., Ritter, H., Friedman, C., & Fitts, D. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.5.1242 · Cited by 128
Self-citationHigh-dose dexamethasone for prevention of cis-platin-induced vomiting
Aapro, M., & Alberts, D. (1981) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00258206 · Cited by 127
Ruff, P., Paska, W., Goedhals, L., Pouillart, R., Rivière, A., Vorobiof, D., Bloch, B., Jones, A. L., Martin, C., Brunet, R., et al. (2009) · Oncology · doi:10.1159/000227321 · Cited by 124
Morrow, G. R., & Dobkin, P. L. (1988) · Clinical Psychology Review · doi:10.1016/0272-7358(88)90077-3 · Cited by 123
Self-citationKris, M. G., Gralla, R. J., Clark, R. A., & Tyson, L. B. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.4.659 · Cited by 121
Self-citationBonneterre, J. M., Chevallier, B., Metz, R., Fargeot, P., Pujade-Lauraine, É., Spielmann, M., Tubiana-Hulin, M., Paes, D., & Bons, J. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.6.1063 · Cited by 117
Kaizer, L., Warr, D. G., Hoskins, P. J., Latreille, J., Lofters, W., Yau, J., Palmer, M. K., Zee, B. C.-Y., Levy, M., & Pater, J. L. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.5.1050 · Cited by 115
Methodology of antiemetic trials: A review
Tonato, M., Roila, F., & Favero, A. D. (1991) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a057871 · Cited by 113
Roila, F., Tonato, M., Basurto, C., Bella, M., Passalacqua, R., Morsia, D., Dicostanzo, F., Donati, D., Ballatori, E., & Tognoni, G. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.1.141 · Cited by 112
The effect of a susceptibility to motion sickness on the side effects of cancer chemotherapy
Morrow, G. R. (1985) · Cancer · doi:10.1002/1097-0142(19850615)55:12<2766::aid-cncr2820551207>3.0.co;2-7 · Cited by 107
Self-citationAnticipatory anxiety in women receiving chemotherapy for breast cancer.
Jacobsen, P. B., Bovbjerg, D. H., & Redd, W. H. (1993) · Health Psychology · doi:10.1037//0278-6133.12.6.469 · Cited by 105
Andrykowski, M. A. (1990) · Psychosomatic Medicine · doi:10.1097/00006842-199007000-00008 · Cited by 104
Zeltzer, L., LeBaron, S., & Zeltzer, P. M. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.6.683 · Cited by 103
Lofters, W., Pater, J. L., Zee, B. C.-Y., Dempsey, E., Walde, D., Moquin, J.-P., Wilson, K. S., Hoskins, P. J., Guevin, R., Verma, S., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.8.2966 · Cited by 103
Ondansetron Study Group, Seynaeve, C., Schuller, J., Buser, K., Porteder, H., Belle, S. V., Sevelda, P., Christmann, D., Schmidt, M., Kitchener, H. C., et al. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.241 · Cited by 102
Use of an NK1 Receptor Antagonist to Prevent Delayed Emesis After Cisplatin
Kris, M. G., Pizzo, B. A., Radford, J. E., Inabinet, R., Hesketh, A. M., & Hesketh, P. J. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.11.817 · Cited by 101
Self-citationBurish, T. G., & Tope, D. M. (1992) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(92)90062-m · Cited by 101
Jantunen, I. T., Muhonen, T. T., Kataja, V. V., Flander, M. K., & Teerenhovi, L. M. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90101-k · Cited by 101
Grunberg, S. M., Stevenson, L. L., Russell, C. A., & McDermed, J. E. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.8.1137 · Cited by 101
Self-citationBECK, T. M., Hesketh, P. J., Madajewicz, S., Navari, R. M., Pendergrass, K. B., Lester, E. P., Kish, J. A., Murphy, W. K., Hainsworth, J. D., & Gandara, D. R. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.12.1969 · Cited by 100
Self-citationGralla, R. J., Navari, R. M., Hesketh, P. J., Popovic, W., Strupp, J., Noy, J., Einhorn, L. H., Ettinger, D. S., Bushnell, W., & Friedman, C. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1568 · Cited by 98
Self-citationReview: The Management of Nausea and Vomiting in Clinical Oncology
Craig, J. B., & Powell, B. L. (1987) · The American Journal of the Medical Sciences · doi:10.1097/00000441-198701000-00008 · Cited by 97
Lindley, C. M., Bernard, S. A., & Fields, S. M. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.8.1142 · Cited by 96
(1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.2937 · Cited by 96
Morrow, G. R. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.10.1170 · Cited by 95
Self-citationPhase II Trials of the Serotonin Antagonist GR38032F for the Control of Vomiting Caused by Cisplatin
Kris, M. G., Gralla, R. J., Clark, R. A., & Tyson, L. B. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.1.42 · Cited by 93
Self-citationPriestman, T. J., Roberts, J. T., Lucraft, H. H., Collis, C., Adams, M., Upadhyaya, B. K., & Priestman, S. G. (1990) · Clinical Oncology · doi:10.1016/s0936-6555(05)80790-3 · Cited by 91
Adrenocorticotropic Hormone (ACTH)
Orth, D. N. (1978) · Elsevier eBooks · doi:10.1016/b978-0-12-379260-0.50019-4 · Cited by 90
Shiling, D. J., Stillman, R. C., Chang, A. E., Goldberg, N. H., Seipp, C. A., Barofsky, I., & Rosenberg, S. A. (1981) · Cancer · doi:10.1002/1097-0142(19810401)47:7<1746::aid-cncr2820470704>3.0.co;2-4 · Cited by 89
(1989) · PubMed · Cited by 87
Burish, T. G., & Carey, M. P. (1986) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.54.5.593 · Cited by 87
BECK, T. M., Ciociola, A. A., Jones, S. E., et al. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-6-199303150-00002 · Cited by 87
Gralla, R. J., Tyson, L. B., Bordin, L. A., Clark, R. A., Kelsen, D. P., Kris, M. G., Kalman, L., & Groshen, S. G. (1984) · PubMed · Cited by 87
Self-citationNavari, R. M., Kaplan, H. G., Gralla, R. J., Grunberg, S. M., Palmer, R. H., & Fitts, D. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.10.2204 · Cited by 85
Self-citationRoila, F. (1995) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a059320 · Cited by 85
Audhuy, B., Cappelaere, P., Martín, M., Cervantes, A. M. R., Fabbro, M., Rivière, A., Khayat, D., Bleiberg, H., Faraldi, M., Claverie, N., et al. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00025-1 · Cited by 84
Andrykowski, M. A., Jacobsen, P. B., Marks, E., Gorfinkle, K., Hakes, T. B., Kaufman, R. J., Currie, V. E., Holland, J. C., & Redd, W. H. (1988) · Cancer · doi:10.1002/1097-0142(19881215)62:12<2607::aid-cncr2820621226>3.0.co;2-s · Cited by 83
Kaasa, S., Kvaløy, S., Dicato, M. A., et al. (1990) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(90)90227-k · Cited by 81
The Management of Chemotherapy-Induced Nausea and Vomiting
Gralla, R. J., Tyson, L. B., Kris, M. G., & Clark, R. A. (1987) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30871-9 · Cited by 81
Self-citation(1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.124 · Cited by 80
Morrow, G. R. (1992) · Europe PMC (PubMed Central) · Cited by 77
Self-citationDanjoux, C. E., Rider, W. D., & Fitzpatrick, P. J. (1979) · Clinical Radiology · doi:10.1016/s0009-9260(79)80203-2 · Cited by 76
Levitt, M., Warr, D. G., Yelle, L., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304153281503 · Cited by 73
Burish, T. G., & Lyles, J. N. (1979) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/0005-7916(79)90017-x · Cited by 72
Quality of Life Studies in Chemotherapy-Induced Emesis
Osoba, D., Zee, B. C.-Y., Warr, D. G., Kaizer, L., Latreille, J., & Pater, J. L. (2009) · Oncology · doi:10.1159/000227647 · Cited by 71
Self-citationReview paper: Selectivity of 5-HT3 receptor antagonists and anti-emetic mechanisms of action
Freeman, A., Cunningham, K., & Tyers, M. B. (1992) · Anti-Cancer Drugs · doi:10.1097/00001813-199204000-00001 · Cited by 70
Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy
McCabe, M., Smith, F. P., Macdonald, J. S., Woolley, P. V., Goldberg, D., & Schein, P. S. (1988) · Investigational New Drugs · doi:10.1007/bf00175407 · Cited by 70
Anticipatory Nausea and Vomiting in Pediatric Cancer Patients
Dolgin, M. J., Katz, E. R., McGinty, K., & Siegel, S. E. (1985) · PEDIATRICS · doi:10.1542/peds.75.3.547 · Cited by 70
5-HT3 antagonist ondansetron--an effective outpatient antiemetic in cancer treatment.
Pinkerton, R., Williams, D., Wootton, C. M., Meller, S., & McElwain, T. J. (1990) · Archives of Disease in Childhood · doi:10.1136/adc.65.8.822 · Cited by 69
Balfour, J. A. B., & Goa, K. L. (1997) · Drugs · doi:10.2165/00003495-199754020-00008 · Cited by 67
Significance and detection of dysplasia in chronic colitis
Goldman, H. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19961201)78:11<2450::aid-cncr29>3.0.co;2-z · Cited by 67
Zeltzer, L. K., Kellerman, J., Ellenberg, L., & Dash, J. D. (1983) · Journal of Adolescent Health Care · doi:10.1016/s0197-0070(83)80023-0 · Cited by 62
Morrow, G. R. (1986) · Cognitive Therapy and Research · doi:10.1007/bf01173295 · Cited by 61
Self-citationPriestman, T. J., Roberts, J. T., & Upadhyaya, B. K. (1993) · Clinical Oncology · doi:10.1016/s0936-6555(05)80086-x · Cited by 61
Fifteen-Year Follow-up of Hyperoxaluria Type II
Sullivan, J. R., Leyden, M. J., & Bell, R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198309293091317 · Cited by 61
Chemotherapy-Related Nausea and Vomiting: Etiology and Management
Morrow, G. R. (1989) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.39.2.89 · Cited by 60
Self-citationPomeroy, M., FENNELLY, J. J., & Towers, M. J. (1986) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00256701 · Cited by 59
Bishop, J. F., Olver, I. N., Wolf, M., Matthews, J. P., Long, M., Bingham, J., Hillcoat, B. L., & Cooper, I. A. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.6.691 · Cited by 59
Addelman, M., Erlichman, C., Fine, S., et al. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.2.337 · Cited by 59
Profiles of emetic action of cisplatin in the ferret: a potential model of acute and delayed emesis
Rudd, J. A., JORDAN, C. C., & Naylor, R. J. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90048-5 · Cited by 57
Methylprednisolone as an Antiemetic
Lee, B. (1981) · New England Journal of Medicine · doi:10.1056/nejm198102193040815 · Cited by 57
Stewart, A., McQuade, B., Cronje, J. D. E., Goedhals, L., Gudgeon, A., Corette, L., Froger, X., Tubiana-Hulin, M., Laplaige, P., Roberts, J. T., et al. (2009) · Oncology · doi:10.1159/000227458 · Cited by 56
Mantovani, G., Macciò, A., Bianchi, A. C., Curreli, L., Ghiani, M., Proto, E. B., & Santona, M. C. (1996) · Cancer · Cited by 55
Prevention of cyclophosphamide/cytarabine-induced emesis with ondansetron in children with leukemia.
Carden, P. A., Mitchell, S. L., Waters, K., Tiedemann, K., & EKERT, H. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.9.1531 · Cited by 54
Anticipatory nausea development in cancer patients: Replication and extension of a learning model
Morrow, G. R., Lindke, J., & Black, P. M. (1991) · British Journal of Psychology · doi:10.1111/j.2044-8295.1991.tb02382.x · Cited by 52
Self-citationModels, Mechanisms and Management of Anticipatory Nausea and Emesis
Morrow, G. R., & Rosenthal, S. N. (2009) · Oncology · doi:10.1159/000227633 · Cited by 48
Self-citationCupissol, D., Serrou, B., & Caubel, M. (1990) · PubMed · Cited by 48
Morrow, G. R., Asbury, R., Hammon, S., & Dobkin, P. (1992) · Health Psychology · doi:10.1037//0278-6133.11.4.250 · Cited by 47
Self-citationGrunberg, S. M., Akerley, W., Krailo, M., Johnson, K. B., Baker, C. R., & Cariffe, P. A. (1986) · Cancer Investigation · doi:10.3109/07357908609017518 · Cited by 46
Self-citationChallis, G. B., & Stam, H. J. (1992) · Health Psychology · doi:10.1037//0278-6133.11.3.181 · Cited by 43
Warr, D. G., Wilan, A., Venner, P. M., et al. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90572-w · Cited by 40
Is Navoban® (tropisetron) as effective as Zofran® (ondansetron) in cisplatin-induced emesis?
Marty, M. E., Kleisbauer, J. P., Fournel, P., Vergnenégre, A., Carlès, P., Loria-Kanza, Y., Simonetta, C., & de Bruijn, K. M. (1995) · Anti-Cancer Drugs · doi:10.1097/00001813-199502001-00004 · Cited by 40
Priestman, S. G., Priestman, T. J., & Canney, P. A. (1987) · Clinical Radiology · doi:10.1016/s0009-9260(87)80151-4 · Cited by 40
Fauser, A. A., Duclos, B., Chemaissani, A., Favero, A. D., Cognetti, F., Díaz‐Rubio, E., Cortés-Funes, H., Conte, P., & Dressler, H. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00132-3 · Cited by 40
Conditioned emotional distress in women receiving chemotherapy for breast cancer.
Jacobsen, P. B., Bovbjerg, D. H., Schwartz, M. D., Hudis, C. A., Gilewski, T. A., & Norton, L. (1995) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.63.1.108 · Cited by 37
The delayed-emesis syndrome from cisplatin: phase III evaluation of ondansetron versus placebo.
Gandara, D. R., Harvey, W. H., Monaghan, G. G., Perez, E. A., Stokes, C., Bryson, J. C., Finn, A. L., & Hesketh, P. J. (1992) · PubMed · Cited by 37
Self-citationNabilone and prochlorperazine: a useful combination for emesis induced by cytotoxic drugs.
Cunningham, D., Forrest, G. J., Soukop, M., Gilchrist, N. L., Calder, I. T., & McArdle, C. S. (1985) · BMJ · doi:10.1136/bmj.291.6499.864 · Cited by 36
Soukop, M. (1990) · PubMed · Cited by 36
Anticipatory nausea and vomiting in cancer patients.
Kvale, G., Hugdahl, K., Asbjørnsen, A. E., Rosengren, B., Lote, K., & Nordby, H. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.59.6.894 · Cited by 34
Methylprednisolone for the Control of CMF-Induced Emesis
Chiara, S., Campora, E., Lionetto, R., Bruzzi, P., & Rosso, R. (1987) · American Journal of Clinical Oncology · doi:10.1097/00000421-198706000-00021 · Cited by 34
Martoni, A. A., Angelelli, B., Guaraldi, M., Strocchi, E., & Pannuti, F. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00519-6 · Cited by 34
Corticosteroids, dopamine antagonists and other drugs
Herrstedt, J., Aapro, M., Smyth, J. F., & Favero, A. D. (1998) · Supportive Care in Cancer · doi:10.1007/s005200050155 · Cited by 33
Antiemetic Efficacy of Nabilone and Dexamethasone
Niiranen, A., & Mattson, K. V. (1987) · American Journal of Clinical Oncology · doi:10.1097/00000421-198708000-00014 · Cited by 32
Treatment of nausea and vomiting caused by cancer chemotherapy
László, J. (1982) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(82)80029-7 · Cited by 32
Bonneterre, J., & Hecquet, B. (1995) · PubMed · Cited by 32
Decreased Cisplatin-Induced Nausea and Vomiting with Chronic Alcohol Ingestion
(1983) · New England Journal of Medicine · doi:10.1056/nejm198309293091316 · Cited by 32
Nabilone: an effective antiemetic agent in patients receiving cancer chemotherapy
Einhorn, L. H. (1982) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(82)80037-6 · Cited by 31
Ungerleider, J. T., Andrysiak, T., Fairbanks, L. A., Tesler, A. S., & Parker, R. (1984) · Radiology · doi:10.1148/radiology.150.2.6318262 · Cited by 28
Diamond-blackfan anemia and malignancy. A case report and a review of the literature
van Dijken, P. J., & Verwijs, W. (1995) · Cancer · doi:10.1002/1097-0142(19950801)76:3<535::aid-cncr2820760331>3.0.co;2-k · Cited by 28
Smith, D. B., Newlands, E. S., Rustin, G. J. S., Begent, R., Crawford, S. M., Bagshawe, K. D., & Carruthers, L. (1990) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00684888 · Cited by 22
Goldstein, D., Levi, J. A., Woods, R. L., Russell, J. A., Morgan, J., & Kerestes, Z. (2009) · Oncology · doi:10.1159/000226695 · Cited by 22
SUSCEPTIBILITY TO MOTION SICKNESS AND CHEMOTHERAPY-INDUCED SIDE-EFFECTS
Morrow, G. R. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90436-7 · Cited by 12
Self-citationOsoba, D., Erlichman, C., Willan, A. R., et al. (1986) · PubMed · Cited by 12
Self-citationCampora, E., Chiara, S., Bruzzi, P., Scarsi, P., & Rosso, R. (1985) · Tumori Journal · doi:10.1177/030089168507100508 · Cited by 8
Study design in evaluation of combined modality treatment
Howel, D., & Jones, M. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90402-y · Cited by 2
Walsh (1995) · doi:10.1002/1097-0142(19951201)76:11
Cited by
Pfister, D. G., Johnson, D. H., Azzoli, C. G., Sause, W., Smith, T. J., Baker Jr, S., Olak, J., Stover, D., Strawn, J. R., Turrisi, A. T., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.053 · Cited by 1,413
Self-citationAntiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
Basch, E., Prestrud, A. A., Hesketh, P. J., Kris, M. G., Feyer, P. C., Somerfield, M. R., Chesney, M., Clark-Snow, R. A., Flaherty, A. M., Freundlich, B., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.4614 · Cited by 1,059
Self-citationChemotherapy-Induced Nausea and Vomiting
Hesketh, P. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0706547 · Cited by 827
Self-citationHesketh, P. J., Grunberg, S. M., Gralla, R. J., Warr, D. G., Roila, F., de Wit, R., Chawla, S. P., Carides, A. D., Ianus, J., Elmer, M. E., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.095 · Cited by 779
Self-citationAmerican Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006
Kris, M. G., Hesketh, P. J., Somerfield, M. R., Feyer, P., Clark-Snow, R., Koeller, J. M., Morrow, G. R., Chinnery, L. W., Chesney, M. J., Gralla, R. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.9591 · Cited by 740
Self-citation
Metadata
- Authors
- Gralla, R. J., Osoba, D., Kris, M. G., Kirkbride, P., Hesketh, P. J., Chinnery, L. W., Clark-Snow, R., Gill, D. P., Groshen, S., Grunberg, S., Koeller, J. M., Morrow, G. R., Perez, E. A., Silber, J. H., & Pfister, D. G.
- Venue
- Journal of Clinical Oncology
- Published
- 1999-09
- Volume
- 17
- Issue
- 9
- Pages
- 2971-2971
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2125540170
- Cited by
- 664
- References
- 132
- FWCI
- 30.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.